Monoclonal Mouse anti‑Human APOBR / APOB48R Antibody (clone OTI2G6, Carrier‑free, aa780‑1088, WB) LS‑C791101
Monoclonal Mouse anti‑Human APOBR / APOB48R Antibody (clone OTI2G6, Carrier‑free, aa780‑1088, WB) LS‑C791101
Antibody:
APOBR / APOB48R Mouse anti-Human Monoclonal (aa780-1088) (Carrier-free) (OTI2G6) Antibody
Format:
Unconjugated, Carrier-free
Overview
Antibody:
APOBR / APOB48R Mouse anti-Human Monoclonal (aa780-1088) (Carrier-free) (OTI2G6) Antibody
Format:
Unconjugated, Carrier-free
Specifications
Description
APOB48R antibody LS-C791101 is an unconjugated mouse monoclonal antibody to human APOB48R (APOBR) (aa780-1088). Validated for WB.
Target
Human APOBR / APOB48R
Synonyms
APOBR | Apolipoprotein B-100 receptor | Apolipoprotein B48 receptor | APOB48R | ApoB-48R | Apolipoprotein B receptor | Apolipoprotein B-48 receptor | APOB100R | Apolipoprotein B100 receptor
Reactivity
Human
(tested or 100% immunogen sequence identity)
Clonality
IgG1
Monoclonal
Conjugations
Unconjugated
Purification
Purified from ascites.
Modifications
Carrier-free.
Also available
Unmodified.
Immunogen
Human recombinant protein fragment corresponding to amino acids 780-1088 of human APOBR(NP_061160) produced in E.coli.
Usage
Applications should be user optimized.
Presentation
PBS, pH 7.3, 8% Trehalose
Reconstitution
Reconstitute with PBS pH 7.3. To use this carrier-free antibody for conjugation experiment, we strongly recommend you to perform another round of desalting process.
Storage
Store at -20°C. Avoid freeze-thaw cycles.
Restrictions
For research use only. Intended for use by laboratory professionals.
Guarantee
This antibody carries the LSBio 100% Guarantee.
LSBio Guarantee
Featured Products
Species:
Human, Rat
Applications:
Western blot
Species:
Mouse, Rat
Applications:
Peptide Enzyme-Linked Immunosorbent Assay
Source:
E. coli
Tag:
His-GST
Request SDS/MSDS
To request an SDS/MSDS form for this product, please contact our Technical Support department at:
Technical.Support@LSBio.com
Requested From: United States
Date Requested: 11/22/2024